Slate Path Capital »

Apellis Pharmaceuticals shares owned by Slate Path Capital

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Slate Path Capital from 13F filings

Historical chart of Slate Path Capital investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Slate Path Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Slate Path Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $79M 2.1M 38.04